CureLab Oncology

Plague bacterium Yersinia pestis, scientifically accurate 3D illustration showing structure of the cell with DNA, plasmids and ribosomes

Oncology company receives $3M from biotech investor

7 March 2023

Dr John Ballantyne, co-founder of Aldevron, has invested $3 million in CureLab Oncology and CureLab Veterinary. The two sister companies have developed an anti-cancer and anti-inflammatory drug that was contract-manufactured by Aldevron at the time Dr Ballantyne served there as chief scientific officer. Both CureLab Oncology and CureLab Veterinary are developing therapies that employ plasmids […]